Atara Biotherapeutics Inc (ATRA)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current ATRA market cap is 35.83M. The company's latest EPS is USD -56.1797 and P/E is -0.13.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 957k | 2.14M | 4.25M | 27.36M | 28.64M |
| Operating Income | -71.63M | -72.72M | -59.96M | -31.25M | -18.23M |
| Net Income | -71.11M | -69.8M | -60.45M | -31.75M | -19.05M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 20.34M | 63.57M | 8.57M |
| Operating Income | -295.68M | -309.05M | -340.46M | -280.51M | -276.01M |
| Net Income | -290.98M | -306.62M | -340.14M | -230M | -276.13M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 246.44M | 188.79M | 165.5M | 165.27M | 117.28M |
| Total Liabilities | 238.99M | 239.63M | 264.74M | 263.58M | 228.15M |
| Total Equity | 7.45M | -50.84M | -99.23M | -98.31M | -110.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 342.94M | 588.12M | 468.13M | 376.42M | 165.5M |
| Total Liabilities | 52.16M | 125.78M | 188.51M | 249.78M | 264.74M |
| Total Equity | 290.78M | 462.34M | 279.61M | 126.64M | -99.23M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -91.23M | -142.57M | -192.98M | -29.61M | -40.26M |
| Investing | 43.48M | 113.92M | 123.87M | 14.72M | 21.91M |
| Financing | 706k | 498k | 2.01M | 24.14M | 23.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -235.63M | -180.76M | -220.52M | -270.43M | -192.98M |
| Investing | 60.46M | -120.73M | 22.26M | 202.96M | 123.87M |
| Financing | 188.79M | 427.57M | 103.94M | 53.08M | 2.01M |
| Market Cap | 35.83M |
| Price to Earnings Ratio | -0.13 |
| Price to Sales Ratio | 4.16 |
| Price to Cash Ratio | 1.38 |
| Price to Book Ratio | -0.36 |
| Dividend Yield | - |
| Shares Outstanding | 4.92M |
| Average Volume (1 week) | 107.62k |
| Average Volume (1 Month) | 235.33k |
| 52 Week Change | -83.24% |
| 52 Week High | 45.75 |
| 52 Week Low | 4.965 |
| Spread (Intraday) | 0.07 (0.96%) |
| Company Name | Atara Biotherapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.atarabio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
